Potentiated Vaccine
for Global Immunization
Company motto
- Potentiates
vaccine for global immunization
- No child left alone without vaccine
Vision statement
- Innovative
technology for novel vaccine
- Cold
chain free nasal vaccine
- Peptide
vaccine without pathogen
- Low cost T-Cell therapy for cancer and infectious disease
What NA Vaccine Institute has
- An adjuvant for potentiated vaccine
- An adjuvant for both parenteral and mucosal vaccination
- An adjuvant with a potent cell mediated immunity for cancer vaccines
- The cost effective production system for the adjuvant
- Produces 100K dose of the adjuvant in less than a month
What NA Vaccine Institute does
Adjuvant related business;
Licensing out of the vaccine adjuvant and/or contract research for the adjuvant development
- Development of adjuvant for more potentiated but safer vaccines
- Development for adjuvant for more effective parentreal and mucosal vaccine
- Development for adjuvant for oral or nasal vaccine
Vaccine development;
Own internal programs and collaboration with others
- Nasal flu vaccine with a broad spectrum protection
- Nasal vaccine without a medical staff
- Vaccine without cold chain
- Peptide based vaccine
- Neoantigenic cancer vaccine
Where NA Vaccine Institute is heading to
- Development of novel adjuvant and
enhanced vaccine for global immunization with lower cost and risk.
- Vaccines with the
breakthrough features of the broad spectrum specificity by intradermal, oral, or nasal delivery routes.
- Vaccines with reduce cost and improve
efficacy without cold chain
- Peptide vaccines without pathogen
- Setting up the industrial standard for the production of the novel adjuvant molecule,
the industrial scale production, and QC guide line for each production steps.
